Cyclosporine immunomodulation retards regeneration of surgically transected corneal nerves

Abed Namavari1, Shweta Chaudhary, Jin-Hong Chang

  • 1Corneal Neurobiology Laboratory, Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, College of Medicine, Chicago, Illinois 60612, USA.

Abstract

Insights

Cyclosporine (CsA) eye drops reduce corneal nerve regeneration after surgery by inhibiting cytokine expression and directly impairing neurite outgrowth. This immunomodulation impacts nerve fiber density recovery.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Immunology

Background:

  • Corneal nerve damage can impair vision and sensation.
  • Understanding factors influencing nerve regeneration is crucial for effective treatment.
  • Immunomodulatory drugs may impact neural healing processes.

Purpose of the Study:

  • To investigate the effect of cyclosporine (CsA) on corneal nerve reinnervation following surgical injury.
  • To determine if CsA influences the expression of key neurotrophic and inflammatory factors.
  • To assess the direct impact of CsA on neuronal growth in vitro.

Main Methods:

  • Lamellar corneal surgery was performed on Thy1-YFP+ mice, followed by treatment with artificial tears or CsA eye drops.
  • In vivo microscopy tracked changes in nerve fiber density (NFD).
  • Quantitative PCR analyzed cytokine expression (IL6, TNF-α), and compartmental cultures assessed CsA's effect on neurite outgrowth.

Main Results:

  • CsA treatment led to a significantly lower increase in corneal nerve fiber density compared to controls.
  • Expression of IL6 and TNF-α was reduced in the CsA group.
  • In vitro, CsA directly inhibited neurite outgrowth from trigeminal ganglion neurons.

Conclusions:

  • Cyclosporine (CsA) impairs corneal nerve regeneration after surgical transection.
  • CsA reduces pro-inflammatory cytokine expression in the cornea.
  • CsA exhibits a direct inhibitory effect on neuronal growth, hindering nerve repair.